250 THE α5 and αV INTEGRINS ARE REGULATED DURING CHONDROCYTE DIFFERENTIATION AND OSTEOARTHRITIS FOR GDF-5 AND BMP-7  by Aguirre-Sánchez, H.I. et al.
S120 Poster Presentations / Osteoarthritis and Cartilage 19S1 (2011) S53–S236
oxide (NO) in conditioned media were determined. Activation of NF-
úB and Akt pathways was assessed with enzyme-linked immunosorbent
assay (ELISA). Involvement of CD44 in HBFN-f action was evaluated using
anti-CD44 antibody and high molecular weight hyaluronan (HA).
Results: In chondrocyte monolayer cultures, HBFN-f stimulated NO
production in association with up-regulation of NF-úB and Akt. Inhibition
studies using BAY11–7085 conﬁrmed that NO production by HBFN-f
was dependent on NF-úB pathway. Inhibition studies using LY294002
revealed the requirement of PI3K/Akt pathway for NF-úB activation by
HBFN-f. Anti-CD44 treatment with anti-CD44 antibody and HA resulted
in signiﬁcant inhibition of HBFN-f actions on activation of Akt and NF-úB,
and on NO production.
Conclusions: This is the ﬁrst study demonstrating that HBFN-f activates
PI3K/Akt pathway leading to up-regulation of NF-úB through interaction
with CD44. Elucidation of intracellular pathways activated by ﬁbronectin
fragments may be helpful to understand the pathological process in OA
cartilage destruction.
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PGE2 AND FGF-2 UPREGULATE ACTIVITIES OF THE HUMAN
F-SPONDIN PROMOTER
M. Attur1, Q. Yang2, J. Wang3, K. Mix4, G. Palmer1, S.B. Abramson1.
1NYU Hosp. for Joint Diseases, New York, NY, USA; 2NYU Sch. of Med.,
New York, NY, USA; 3NYU Cancer Inst., NYU Ctr. for Hlth.Informatics and
Bioinformatics, New York Univ. Sch. of Med., New York, NY, USA; 4Dept. of
Biological Sci., Loyola Univ. New Orleans, New Orleans, LA, USA
Purpose: The extracellular matrix protein, F-spondin is a marker of both
hypertrophic and osteoarthritic cartilage. Understanding the mechanisms
that regulate its expression could therefore identify key pathways that
regulate chondrocyte activity in development and disease. In this study
we investigated transcriptional regulation of human F-spondin via the
cloning and characterization of its 5′ regulatory (promoter) region.
Methods: Genomic sequence containing the 5′ regulatory region of
F-spondin was obtained by PCR of human total genomic DNA (Clontech)
using upstream primers designed from F-spondin genomic sequence
available at the gene database www.ncbi.nlm.nih.gov, gene ID: 10418.
PCR fragments were cloned into TA cloning vectors (Invitrogen) for
sequencing and subcloned into pGL3 Luciferase Reporter Vectors
(Promega) for functional analysis. Luciferase assays were performed 36
h after transfection in the human chondrosarcoma cell line, SW1353.
Results: An upstream 2.4 kb genomic sequence of human F-spondin was
obtained by PCR, subcloned and sequenced bidirectionally. DNA sequence
ﬁdelity was conﬁrmed using the NCBI blast alignment search tool. DNA
sequence analysis revealed the presence of TATA box at position −74 and
identiﬁcation of transcription factor binding sites was performed using
the JASPAR CORE database (http://jaspar.genereg.net/). High scoring
putative binding sites within the 2.4 kb promoter region included NURR1
(NR4A2-nuclear receptor), NFAT, SOX-10 and CREB1. Functional promoter
activity was assessed by transient transfection of pGL3 luciferase vectors
encoding 2.4 kb (pFS-2.4Luc) and 0.5 kb (pFS-0.5Luc) of F-spondin
upstream genomic sequence. In human chondrocytes, both pFS-2.4Luc
and pFS-0.5Luc signiﬁcantly increased luciferase activity above a pGL3
promoterless control vector, 20- and 70-fold, respectively. Since we
have previously observed that F-spondin mRNA levels are induced by
FGF-2 and PGE2 in OA chondrocytes, we examined their effects on
promoter activity. PGE-2 (10 uM) stimulated F-spondin luciferase activity
10–20-fold for both 2.4 and 0.5 kb promoter constructs (p< 0.001)
above unstimulated controls. Cotransfection of a cDNA encoding NURR1,
a transcription factor induced by PGE2 in human chondrocytes, also
increased luciferase activity (100-fold) irrespective of promoter length.
This is consistent with the presence of multiple putative NURR1 binding
sites (~16) throughout the 2.5 kb promoter region. Conversely, FGF-2
(25ng/ml) signiﬁcantly increased luciferase activity of pFS-0.5Luc (2-
fold; p < 0.05) but not pFS-2.4Luc. This ﬁnding suggests that regulation
of F-spondin via FGF-2 occurs via regulatory regions within its proximal
0.5 kb region.
Conclusions: Our results indicate that both developmental (FGF-2)
and proinﬂammatory (PGE2) factors induce F-spondin expression in
chondrocytes via discrete regions in its promoter. Sequence analysis and
transfection studies suggest that NURR1 may mediate PGE2 induction
of F-spondin via multiple binding sites in the promoter region. The
current ﬁndings are consistent with previous observations demonstrating
overlapping pro-inﬂammatory/catabolic effects of PGE2, NURR1 and
F-spondin in OA chondrocytes.
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EXPRESSION OF HUMAN ENDOGENOUS RETROVIRUS HERV-K18 IN
OSTEOARTHRITIS PATIENTS
J. Lamas, M. Garcia-Montojo, J. Hoyas, I. Dominguez-Mozo, E. Villafuertes,
P. Tornero-Esteban, A. Arias-Leal, L. Abasolo-Alcazar, R. Alvarez-Lafuente,
B. Fernandez-Gutierrez. Hosp. Clinico San Carlos, Madrid, Spain
Purpose: To evaluate the possible involvement of HERV-K18 in OA,
through the analysis of the expression levels of this endogenous
retrovirus in OA patients in comparison with healthy controls, and
through the analysis of different qualitative and quantitative clinical
variables.
Methods: 113 OA patients and 62 controls were included in the
study. To analyze HERV-K18 mRNA expression, quantitative RT-PCR
was performed; the transcriptional expression was expressed in a
relative manner as a normalization ratio (NR), and for controls were
assigned a NR=1. The WOMAC (Western Ontario and McMasters
Universities Osteoarthritis Index), Lequesne Index, and the Stanford
Health Assessment Questionnaire (HAQ) were analyzed in relation to
the expression levels of HERV-K18.
Results: In our study, 54 of 113 OA patients (47.8%) and 22 of 62 controls
(35.5%) showed detectable expression levels of HERV-K18. We found
statistical signiﬁcant differences when we compared the results of the
Womac Index, Lequesne Index for knee and hip, and HAQ between
OA patients with higher expression (NR > 10) vs. OA patients without
HERV-K18 expression (p =0.0003, p = 0.0005, p = 0.002, and p=0.05,
respectively), and also when the comparison was made between OA
patients with higher expression (NR > 10) vs. OA patients with low
expression of HERV-K18 (NR=1) for the Womac Index, and Lequesne
Index for knee and hip (p = 0.002, p = 0.013, and p=0.006, respectively).
Conclusions: It seems to be a relation between the health status
measurement systems and severity index for OA with the levels of
expression of HERV-K18. These results suggest a possible involvement of
HERV-K18 in the etiopathogenesis of the disease.
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THE a5 and aV INTEGRINS ARE REGULATED DURING CHONDROCYTE
DIFFERENTIATION AND OSTEOARTHRITIS FOR GDF-5 AND BMP-7
H.I. Aguirre-Sa´nchez1, R.F. Abarca-Buis1, J.B. Kouri2, M.C. Velasquillo1,
J.C. Ibarra1, D. Garciadiego-Ca´zares1. 1Intituto Natl. de Rehabilitacio´n,
Ciudad de Me´xico, Mexico; 2CINVESTAV, Ciudad de Me´xico, Mexico
Purpose: In this study we proposed that b1 integrins family regulate
chondrocyte differentiation in the articular cartilage, as well as in the
scar and blood vessels formation during OA. This is suggested on the basis
of the integrins pattern expression on different stages of osteoarthritis in
a experimental OA rat model.The effect of GDF-5 (growth differentiation
factor 5) and BMP-7 (bone morphogenetic protein) on chondrocytes
differentiation is also analyzed here.
Methods: The experimental OA animal model, rats were subject to partial
meniscectomy on the right knee and they exercised daily to induce OA.
After the 5, 10 and 20 days, the knees were dissected and ﬁxed in 4%
PFA overnight. Then, tissues were dehydrated and parafﬁn-embedded
for preparing histological sections. Expression pattern of Integrin a5
and aV, Gdf-5, Bmp-7, and chondrocyte differentiation markers were
determinate by Immunohistochemistry and In situ hybridization. In vitro
assay for chondrogenesis were made by micromasses cultures, the cells
formed cartilaginous nodules and the effect of GDF-5 and BMP-7 on
micromasses was then tested. By immunohistochemistry were determine
the expression of different integrins subunits and MEC molecules typical
of articular cartilage. Assay for endochondral ossiﬁcation were made
by mouse knee cultures, 20 days old mice were used. The knees were
longitudinally dissected and placed on air liquid inter-phase using BGJb
medium with 0.1% bovine serum albumin. Organ cultures then were
kept for 4 days at 37°C in a 5% CO2 incubator. Hedgehog signaling was
blockade with 10 nM Cyclopamine.
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Results: Loss of a5 integrin expression was related to chondrocyte
dedifferentiation in the osteoarthritic articular cartilage, while a1, a2
and a3 integrin expression increased in ﬁbrous areas in osteoarthritic
cartilage. The aV integrin was expressed in hyperthrophic cartilage
and increased in the articular cartilage of osteoarthritic rats, where
bone was developed and neovascularization was observed. The effect of
GDF-5 (growth differentiation factor 5) and BMP-7 (bone morphogenetic
protein 7) on integrins expression during chondrocytes differentiation
was also analyzed. A micromasses culture system of mouse embryo
mesenchymal cells, were treated with GDF-5 or BMP-7 for 4 and 6 days.
The expression of integrins was analyzed by immunohistochemistry.
GDF-5 induced the expression of a5 sub-unit while BMP-7 induced
the expression of aV sub-unit. This suggests a switch in the signal
for chondral differentiation towards hypertrophy, where GDF-5 could
keep the state of the articular chondrocyte and BMP-7 would induce
hypertrophy. The typical chondrocyte phenotype in the articular cartilage
is preserved due to the presence of Indian hedgehog (Ihh), which is
dependent on a5 integrin and GDF-5 to keep the articular cartilage and
prevent hypertrophy. This was supported by decrease of Ihh expression in
articular cartilage during OA. Treating mouse knees organ cultures with
Cyclopamine an Ihh signaling inhibitor, articular cartilage ossiﬁcation
was observed similarly with OA rat knees, probably by a process
apparently similar to endochondral ossiﬁcation.
Conclusions: The typical chondrocyte phenotype in the articular
cartilage is preserved due to the presence of Indian hedgehog (Ihh),
which is dependent on a5 integrin and GDF-5 to keep the articular
cartilage phenotype and prevent hypertrophy and OA.
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ALARMINS S100A8 AND S100A9 ELICIT AN ENHANCED CATABOLIC
RESPONSE IN CHONDROCYTES FROM OSTEOARTHRITIS PATIENTS
THAT IS TOLL LIKE RECEPTOR 4 DEPENDENT
R.F. Schelbergen1, A.B. Blom1, M.H. van den Bosch1, A. Sloetjes1,
W. Schreurs2, T. Vogl3, J. Roth3, W.B. van den Berg1, P.L. van Lent1. 1Dept.
Rheumatology, Radboud Univ. Nijmegen Med. Ctr., Nijmegen, Netherlands;
2Dept. Orthopaedics, Radboud Univ. Nijmegen Med. Ctr., Nijmegen,
Netherlands; 3Inst. of Immunology, Univ. of Muenster, Muenster, Germany
Purpose: S100A8 and S100A9 are two Ca2+-binding proteins classiﬁed
as damage associated molecular patterns (DAMPs) or alarmins that
are found in high amounts in the synovial ﬂuid of osteoarthritis (OA)
patients. Previously, we found that S100A8 and S100A9 are associated
with cartilage degradation in murine collagenase-induced OA. We also
showed that S100A8 and S100A9 stimulate expression and activity of
matrix metalloproteinases (MMPs) and pro-inﬂammatory cytokines in
murine chondrocytes. In the current study, we investigated whether and
via which receptor S100A8 and/or S100A9 can have a catabolic effect on
chondrocytes from OA patients.
Methods: Using immunohistochemistry, we stained for S100A8 and
S100A9 protein, MMPs and a cartilage breakdown epitope speciﬁc for
MMPs (VDIPEN) in cartilage from OA donors. Isolated chondrocytes or
explants from OA and non-OA donors were stimulated with S100A8
and/or S100A9. mRNA and protein levels of MMPs, cytokines and
cartilage matrix molecules were determined with RT-qPCR and Luminex.
For receptor blocking studies, speciﬁc inhibitors for Toll-like receptor
4 (TLR4) (intracellular TAK242) and RAGE and carboxylated glycans
(blocking antibodies) were used.
Results: In cartilage of OA patients, localisation of S100A8 and S100A9
protein was found close to chondrocytes and was associated with
proteoglycan (PG) depletion, MMP1 and -3 and VDIPEN expression.
Stimulation of chondrocytes with S100A8 and S100A9 caused a
signiﬁcant upregulation of MMP1, -3, -9 and -13 at the mRNA (4.7-fold
mean increase) and the protein level (3.0-fold mean increase). Moreover,
S100A8 and S100A9 caused a huge increase in cytokine and chemokine
expression. IL-6, IL-8 andMCP-1 were all greatly increased by S100A8 and
S100A9 at both the mRNA (19.7-fold mean increase) as well as the protein
level (28.8-fold mean increase). Thereby, the expression of anabolic
markers (aggrecan and collagen type II) was signiﬁcantly reduced at the
mRNA level (2.7-fold mean decrease). Together, upregulation of MMPs
and cytokines and downregulation of production of cartilage matrix
molecules favor cartilage loss by the OA chondrocyte.
Blocking TLR4 inhibited the upregulation of MMPs, IL-6, IL-8, MCP-1
and collagen type II by S100A9 in OA chondrocytes. In contrast, the
blocking of carboxylated glycans and RAGE did not alter the S100-effects.
Finally, the catabolic effect of S100A8 and S100A9 was signiﬁcantly more
pronounced in chondrocytes from OA patients when compared to non-
OA. TLR4 mRNA expression was enhanced in OA chondrocytes, which
might be the underlying mechanism of increased sensitivity.
Conclusions: S100A8 and S100A9 have a catabolic effect on human
chondrocytes that is dependent on TLR4. OA chondrocytes are more
sensitive for S100-stimulation than normal chondrocytes.
This study underlines the potential of S100A8 and S100A9 as mediators
of cartilage damage during OA.
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F-SPONDIN MEDIATES CATABOLIC EFFECTS ON ARTICULAR
CHONDROCYTES VIA ITS THROMBOSPONDIN REPEAT (TSR) DOMAIN
J. Liu, G. Palmer, Q. Yang, D. Rifkin, M. Attur, S.B. Abramson. NYUHosp.
for Joint Diseases, New York, NY, USA
Purpose: We have previously shown that the thrombospondin-related,
extracellular matrix protein, F-spondin, is upregulated in osteoarthritis
(OA), and induces the production of catabolic mediators, PGE2 and MMP-
13 in cartilage explants in a TGF-b dependent manner. In this study,
we characterize the role of individual protein domains of F-spondin in
modulating its catabolic effects in chondrocytes.
Methods: OA chondrocytes were harvested from tibial cartilage obtained
from OA patients with end-stage disease undergoing knee replacement
surgery. Transient transfections were performed using TransIT-LT1
reagent (Mirus) and cDNAs encoding full length (FS1) or a truncated
C-terminal (FS7) portion of F-spondin coding sequence. Levels of TGF-b1
(R&D systems) and PGE2 (Cayman Chemical) were determined by ELISA,
MMP-13 expression was measured by qRT-PCR (Applied Biosystems).
TGF-b activity was also measured in conditioned media supernatants
by incubation with mink lung epithelial cells (MLEC) expressing a TGF-
b-responsive luciferase reporter.
Results: Consistent with our previous observations of the effects
of intact F-spondin in cartilage explants, overexpression of FS1 in
cultured OA chondrocytes from 3 patients increased expression levels
of MMP-13 ~100% compared to mock-transfected controls. Similarly,
FS1 also increased PGE2 levels by 25% (p < 0.05). Both effects could be
mimicked by transfection with a construct encoding only the c-terminal
TSR repeat domain FS7; MMP-13 and PGE2 levels were elevated by
FS7 above control vector transfected cultures, ~50% (p < 0.005) and
71% (p < 0.05), respectively. Since the F-spondin TSR domain harbors
consensus sequences for latent TGF-b activation (WxxW and KRFK),
we tested whether F-spondin overexpression increases TGF-b levels
and activity in chondrocyte cultures. In OA chondrocytes, TGF-b levels
in culture supernatants were increased 30% by FS1 and 70% by FS7.
Similarly, measurement of active TGF-b using MLEC reporter cells showed
that FS1 and FS7-transfected culture media supernatants stimulated
luciferase activity 30% and 100%, respectively (p < 0.05). Evidence of
enhanced activation of TGF-b was also demonstrated by increased SMAD
signaling. Immunoblot of FS treated chondrocytes showed increased
phosphorylation of SMAD 1, 5, 8 relative to mock transfected cells.
Similarly, both FS1 and FS7 stimulated expression of a SMAD-luciferase
reporter in OA chondrocytes.
Conclusions: Our data provide evidence that F-spondin, via its TSR
domain, can act as a latent TGF-b-activating protein and enhance the
catabolic activity of chondrocytes via induction of MMP-13 and PGE2. The
TSR domain of F-spondin may therefore represent a novel therapeutic
target for slowing cartilage breakdown in OA.
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INHIBITING CALCINEURIN ACTIVITY UNDER PHYSIOLOGICAL
CONDITIONS SELECTIVELY PREVENTS ARTICULAR CHONDROCYTE
HYPERTROPHY
A.E. van der Windt, E. Haak, J.A. Verhaar, H. Weinans, H. Jahr. Erasmus
MC, Rotterdam, Netherlands
Purpose: Proliferation and hypertrophic differentiation of chondrocytes
as well as extracellular matrix (ECM) mineralization and chondrocytes
apoptosis occur during the course of osteoarthritis (OA). OA is
further characterized by an imbalanced production of ECM-degrading
enzymes such as matrix metalloproteinases (MMPs) and aggreganases
(ADAMTS’), which deplete major structural components like collagens
(COLs) and proteoglycans (PGs, e.g. aggrecan) from the ECM. Both
chondrogenic markers are crucial to biomechanical strength and
